<DOC>
	<DOC>NCT00973076</DOC>
	<brief_summary>The primary objective is to assess the safety and tolerability of AZD8055 in Japanese patients with advanced solid tumours.</brief_summary>
	<brief_title>Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Japanese patients with advanced solid tumors for which suitable effective standard treatment does not exist or is no longer effective Relatively good overall health other than cancer Poor bone marrow function (not producing enough blood cells) Poor liver or kidney function Serious concomitant illness</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Phase I, cancer</keyword>
	<keyword>solid tumors</keyword>
	<keyword>advanced solid malignancies</keyword>
	<keyword>dose escalation</keyword>
	<keyword>mTOR Kinase Inhibitor</keyword>
	<keyword>Japanese</keyword>
</DOC>